4.4 Article

Preliminary Estimates of Effectiveness of Monovalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection Among Children Aged 3–5 Years — Increasing Community Access to Testing Program, United States, July 2022–February 2023

Journal

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
Volume 72, Issue 7, Pages 177-182

Publisher

Centers for Disease Control MMWR Office
DOI: 10.15585/mmwr.mm7207a3

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available